SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about updates

25 Nov 2022 Evaluate
Alkem Laboratories has informed that it enclosed disclosure on a consolidated basis, for the half year ended on 30th September, 2022 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5598.15 14.45 (0.26%)
20-Apr-2026 09:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.60
Dr. Reddys Lab 1232.65
Cipla 1242.10
Zydus Lifesciences 944.25
Lupin 2328.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×